← Back to Search

Shared Decision Making Tool for Kidney Transplant Candidates

N/A
Waitlist Available
Research Sponsored by Hennepin Healthcare Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 Years of age or older
Candidate on the kidney transplant waiting list
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months
Awards & highlights

Study Summary

This trial will evaluate an online education tool to help kidney transplant candidates and providers make informed decisions about donor types.

Who is the study for?
This trial is for English-speaking adults over 18 who have been on the kidney transplant waiting list for more than three months. It's not suitable for those under 18, non-English speakers, patients who opt out of research, or anyone unable to give informed consent.Check my eligibility
What is being tested?
The study tests a tool called 'Donor Plan Donor Choice' designed to help kidney transplant candidates make decisions with their doctors about organ offers. Participants will use an online educational tool and discuss donor types with providers.See study design
What are the potential side effects?
Since this trial involves decision-making support rather than medical treatment, there are no direct physical side effects. However, participants may experience stress or anxiety when considering different donor options.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am on the waiting list for a kidney transplant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Willingness to accept donor organs at risk of discard
Secondary outcome measures
Decisional Conflict
Distress
Knowledge
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Shared Decision Making InterventionExperimental Treatment1 Intervention
Receives the Shared Decision Making Intervention
Group II: Usual CareActive Control1 Intervention
Receives Usual Care, eg. usual patient education and counseling for kidney transplant candidates.

Find a Location

Who is running the clinical trial?

Hennepin Healthcare Research InstituteLead Sponsor
90 Previous Clinical Trials
77,077 Total Patients Enrolled
Mayo ClinicOTHER
3,205 Previous Clinical Trials
3,766,684 Total Patients Enrolled
2 Trials studying Kidney Failure
32 Patients Enrolled for Kidney Failure
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,356 Previous Clinical Trials
4,314,966 Total Patients Enrolled
10 Trials studying Kidney Failure
10,720 Patients Enrolled for Kidney Failure

Media Library

Kidney Offer Shared Decision Making Clinical Trial Eligibility Overview. Trial Name: NCT05879302 — N/A
Kidney Failure Research Study Groups: Shared Decision Making Intervention, Usual Care
Kidney Failure Clinical Trial 2023: Kidney Offer Shared Decision Making Highlights & Side Effects. Trial Name: NCT05879302 — N/A
Kidney Offer Shared Decision Making 2023 Treatment Timeline for Medical Study. Trial Name: NCT05879302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still capacity for volunteers to join this clinical experiment?

"As per the information present on clinicaltrials.gov, this trial is not currently recruiting participants. Although initial recruitment began on August 1st 2023 and the post was recently edited on May 25th 2023, those interested in participating will need to look for other active trials as there are 682 available right now."

Answered by AI
~67 spots leftby Nov 2025